II. Mechanism
- Stimulates CNS adrenergic system
- Reduces food seeking behavior
III. Indication
- Short term (12 weeks per year) Obesity Management
- Physician discretion for indication to continue
IV. Classifications
-
DEA Controlled Substance
- Class IV (Limited dependence liability)
V. Dosing
- Start: 8 mg orally three times daily
- Alternative: 15 to 37.5 mg orally daily 10 hours before sleep
Images: Related links to external sites (from Bing)
Related Studies
| phentermine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| PHENTERMINE 15 MG CAPSULE | Generic | $0.13 each |
| PHENTERMINE 30 MG CAPSULE | Generic | $0.14 each |
| PHENTERMINE 37.5 MG CAPSULE | Generic | $0.11 each |
| PHENTERMINE 37.5 MG TABLET | Generic | $0.07 each |
| lomaira (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| LOMAIRA 8 MG TABLET | Generic | $0.52 each |